Click for full image >>
is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.
TG Therapeutics, Inc. Announces Pre-Clinical Data Presentation on TGR-1202 Demonstrating Differentiated Effects on T-Cells
TG Therapeutics, Inc. Announces Issuance of Composition of Matter Patent for TG-1101 in the United States
3 Columbus Circle, 15th Floor, New York, NY 10019 - P:212.554.4484 - Email Us
Web Site Development by Tidal Media Group